UK MHRA approves Eli Lilly's (LLY) Iniuriyo for treatment of breast cancer
Newsquawk Staff ·
UK MHRA approves Eli Lilly's (LLY) Iniuriyo for treatment of breast cancer.
What it means
Eli Lilly's approval for Iniuriyo marks a significant advancement in their oncology portfolio, likely enhancing growth prospects and investor sentiment. Given the competitive landscape in pharmaceuticals, this could provide a strategic edge against peers, particularly if it captures market share in breast cancer treatment. Watch for potential reactions in Eli Lilly's stock and the broader biotech sector as expectations adjust to this news.
- Canada's Competition Bureau says proposed arrangements between Air Canada and United Airlines (UAL) would lead to higher prices, with the Transport Minister set to review the findings of its investigation
- Daily US Conference Calendar - 28th October 2026: JNJ, BA, CAT
- Eli Lilly’s (LLY) retatrutide delivered greater A1C reduction and more than double the weight loss of Novo Nordisk’s (NOVOB DC) Ozempic at its highest approved dose in head-to-head trial
- Biogen Inc. (BIIB) Q3 2026 (USD): Adj. EPS 2.62 (exp. 1.98), Revenue 2.8bln (exp. 2.63bln). Raises lower end of FY26 diluted EPS guidance to USD 12.20-13.00 (exp. 12.23, prev. 12.00-13.00)
- Santander (SAN SM) Q3 (EUR) net 3.43bln (exp. 3.41bln), rev. 16.0bln (prev. 15.3bln Y/Y)
Related headlines
- JPMorgan Chase (JPM) reportedly faces an additional GBP 100-150mln tax bill following the UK government's decision to double the corporation tax surcharge on banks, potentially jeopardising plans for its new London headquarters, Sky News reports43 min ago
- US EQUITY OPEN: Indices rangebound ahead of FOMC and major earnings58 min ago
- Verisk (VRSK) integrates insurance intelligence with Amazon (AMZN) and Microsoft (MSFT) AI platforms1 hour ago
- Senior US Treasury trade official Eric Ettorre will leave to join Netflix (NFLX), reports Axios1 hour ago
- T-Mobile (TMUS) CEO to step down from the board2 hours ago
- US PRE-MARKET MOVERS: SKHY, NXPI, ENPH, APH, GOOGL, HOOD, PPG, VRT, GEV, GEHC, BSX, ETSY, WEN, V2 hours ago
- US Broker Moves: ENPH and DYN downgraded at Oppenheimer; FFIV downgraded at Piper Sandler3 hours ago
- Amphenol (APH) Q3 2026 (USD): Adj. EPS 0.80 (exp. 0.73), Sales 10.2bln (exp. 9.49bln)3 hours ago
- GE Vernova (GEV) expects USD 50-100mln of annual cost synergies from Trench by 2030, according to the conference call3 hours ago
- Etsy Inc. (ETSY) Q3 2026 (USD): EPS 1.00 (exp. 0.77), Revenue 692mln (exp. 668mln)3 hours ago
- Etsy (ETSY) CFO Baker is to leave on March 1st 2027, will remain an advisor through July 1st 20274 hours ago
- Garmin Ltd. (GRMN) Q3 2026 (USD): Adj. EPS 2.76 (exp. 2.41), Revenue 1.99bln (exp. 1.99bln)4 hours ago
- Phillips 66 (PSX) Q3 2026 (USD): Adj. EPS 14.08 (exp. 11.73)4 hours ago
- Aon (AON) Q3 (USD): Adj. EPS 3.36 (exp. 3.30), Revenue 4.1bln (exp. 4.08bln)4 hours ago
- GE Healthcare Technologies Inc. (GEHC) Q3 (USD): Adj. EPS 1.34 (exp. 1.20), Revenue 5.5bln (exp. 5.35bln), Adj. EBIT 913mln (exp. 838.8mln)4 hours ago